Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-05-27 | 2021-07-09 | 140042 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-25 | 2021-07-15 | 134746 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 0.5MG 50MCG | OINTMENT | Resolved | 2021-04-08 | 2021-07-15 | 137212 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-15 | 139734 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140384 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140381 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140687 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140690 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141116 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2021-06-24 | 2021-07-15 | 141486 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
| TEVA-VARENICLINE | 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126951 |
| TEVA-VARENICLINE | 0.5MG 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126955 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |